These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21769051)

  • 1. Public health clinical demonstration project for smoking cessation in american veterans who served since september 11, 2001.
    Zaborowski DE; Dedert EA; Straits-Troster K; Lee S; Wilson SM; Calhoun PS; Moore SD; Acheson S; Hamlett-Berry KW; Beckham JC
    J Addict Med; 2011 Mar; 5(1):79-83. PubMed ID: 21769051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public health clinical demonstration project for smoking cessation in veterans with posttraumatic stress disorder.
    Dedert EA; Wilson SM; Calhoun PS; Moore SD; Hamlett-Berry KW; Beckham JC
    Addict Behav; 2010 Jan; 35(1):19-22. PubMed ID: 19737675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary findings from a clinical demonstration project for veterans returning from Iraq or Afghanistan.
    Beckham JC; Becker ME; Hamlett-Berry KW; Drury PD; Kang HK; Wiley MT; Calhoun PS; Moore SD; Bright MA; McFall ME
    Mil Med; 2008 May; 173(5):448-51. PubMed ID: 18543565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.
    Bailey SR; Crew EE; Riske EC; Ammerman S; Robinson TN; Killen JD
    Paediatr Drugs; 2012 Apr; 14(2):91-108. PubMed ID: 22248234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist.
    Tonstad S
    J Cardiovasc Nurs; 2006; 21(6):433-6. PubMed ID: 17293731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.
    Robles GI; Singh-Franco D; Ghin HL
    Clin Ther; 2008 May; 30(5):800-12. PubMed ID: 18555928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicomponent smoking cessation treatment including mobile contingency management in homeless veterans.
    Carpenter VL; Hertzberg JS; Kirby AC; Calhoun PS; Moore SD; Dennis MF; Dennis PA; Dedert EA; Hair LP; Beckham JC
    J Clin Psychiatry; 2015 Jul; 76(7):959-64. PubMed ID: 25699616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Real-world' effectiveness of smoking cessation treatments: a population study.
    Kotz D; Brown J; West R
    Addiction; 2014 Mar; 109(3):491-9. PubMed ID: 24372901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled study.
    Kalman D; Herz L; Monti P; Kahler CW; Mooney M; Rodrigues S; O'Connor K
    Drug Alcohol Depend; 2011 Nov; 118(2-3):111-8. PubMed ID: 21507585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using policy to increase prescribing of smoking cessation medications in the VA healthcare system.
    Smith MW; Chen S; Siroka AM; Hamlett-Berry K
    Tob Control; 2010 Dec; 19(6):507-11. PubMed ID: 20870742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
    JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abstinence rates and predictors of outcome for smoking cessation: do Brazilian smokers need special strategies?
    Chatkin JM; Mariante de Abreu C; Haggsträm FM; Wagner MB; Fritscher CC
    Addiction; 2004 Jun; 99(6):778-84. PubMed ID: 15139876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination Varenicline/Bupropion Treatment Benefits Highly Dependent Smokers in an Adaptive Smoking Cessation Paradigm.
    Rose JE; Behm FM
    Nicotine Tob Res; 2017 Aug; 19(8):999-1002. PubMed ID: 29054128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of the effectiveness of smoking relapse prevention interventions for abstinent smokers.
    Agboola S; McNeill A; Coleman T; Leonardi Bee J
    Addiction; 2010 Aug; 105(8):1362-80. PubMed ID: 20653619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking characteristics and cessation in patients with thromboangiitis obliterans.
    Jiménez-Ruiz CA; Dale LC; Astray Mochales J; Velázquez Buendía L; de Granda Orive I; Guirao García A
    Monaldi Arch Chest Dis; 2006 Dec; 65(4):217-21. PubMed ID: 17393667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National trends in the provision of smoking cessation aids within the Veterans Health Administration.
    Jonk YC; Sherman SE; Fu SS; Hamlett-Berry KW; Geraci MC; Joseph AM
    Am J Manag Care; 2005 Feb; 11(2):77-85. PubMed ID: 15726855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness of interventions to reduce relapse to smoking following smoking cessation.
    Taylor M; Leonardi-Bee J; Agboola S; McNeill A; Coleman T
    Addiction; 2011 Oct; 106(10):1819-26. PubMed ID: 21561499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.